s-nitrosoglutathione has been researched along with Hepatocellular Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aranda, E; Corrales, FJ; López-Pedrera, C; López-Sánchez, LM; Rodríguez-Ariza, A | 1 |
| Chih, TT; Chiu, HF; Hsian, YM; Tseng, CH; Wu, MJ; Wu, YC | 1 |
| Calmels, S; Hainaut, P; Ohshima, H | 1 |
3 other study(ies) available for s-nitrosoglutathione and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Pharmacological impairment of s-nitrosoglutathione or thioredoxin reductases augments protein S-Nitrosation in human hepatocarcinoma cells.
Topics: Antirheumatic Agents; Auranofin; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Nitrosation; Plicamycin; Proteins; Proteomics; S-Nitrosoglutathione; Spectrometry, Mass, Electrospray Ionization; Thioredoxin-Disulfide Reductase; Tumor Cells, Cultured | 2010 |
Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Colforsin; Cyclic AMP; Cyclic GMP; Drug Interactions; Fluorescein-5-isothiocyanate; Furans; Humans; S-Nitrosoglutathione; Tumor Cells, Cultured | 2003 |
Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein.
Topics: Breast Neoplasms; Carcinoma, Hepatocellular; DNA, Neoplasm; Glutathione; Humans; Liver Neoplasms; Nitric Oxide; Nitroso Compounds; Penicillamine; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |